Hunt for tick virus in limousin: 878 tested

NCT ID NCT05941546

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study tested blood samples from 878 people in Limousin, France, for antibodies against tick-borne encephalitis virus (TBEV). The goal was to see if the virus is present in the region, especially in patients with Lyme disease or neurological symptoms. Researchers also checked spinal fluid for the virus when possible. The study does not test any treatment but aims to understand if TBEV is circulating in Limousin.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If the virus is found, this could show that tick-borne encephalitis is present in Limousin, leading to better awareness and testing.
What could go wrong
This is an observational study, not a treatment trial. It only looks for past exposure, so it cannot prove the virus causes disease or predict future cases.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TICK-BORNE ENCEPHALITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Limoges University Hosiptal

    Limoges, 87000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.